Acurx Pharmaceuticals Inc.

ACXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.06 (-4.32%)

At close: Sep 21, 2026, 4:00 PM ET

$1.31

-$0.02 (-1.50%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-8.09M	-14.1M	-14.58M	-12.09M	-12.81M	-4.6M
Interest Income	125.45K	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.97M	-14.1M	-14.58M	-12.09M	-12.75M	-4.6M
Net Income	-7.97M	-14.1M	-14.58M	-12.09M	-12.75M	-4.6M
Selling & General & Admin	6.26B	8.7M	8.53M	7.34M	10.78M	2.4M
Research & Development	1.83B	5.4M	6.04M	4.75M	2.03M	2.2M
Other Expenses	-8.08B	0	n/a	n/a	n/a	0
Operating Expenses	8.09M	14.1M	14.58M	12.09M	12.81M	4.6M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	8.09M	14.1M	14.58M	12.09M	12.81M	4.6M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	1.5M	851.55K	633.6K	540.8K	510.8K	495.8K
Shares Outstanding (Diluted)	1.5M	851.55K	633.6K	540.8K	510.8K	495.8K
EPS (Basic)	-5.32	-17.59	-23.01	-22.36	-24.96	-9.28
EPS (Diluted)	-5.32	-17.59	-23.01	-22.36	-24.96	-9.28
EBITDA	-7.97M	n/a	-14.58M	-12.09M	-12.75M	n/a
EBIT	-7.97M	-14.1M	-14.58M	-12.09M	-12.75M	-4.6M
Depreciation & Amortization	n/a	14.1M	n/a	n/a	n/a	4.6M